Skip to main content
. 2021 Feb 12;13(4):771. doi: 10.3390/cancers13040771

Figure 2.

Figure 2

Schematic overview of factors influencing plasma concentrations of endoxifen. Known factors are genetic influences (e.g., CYP2D6 polymorphisms but also non-CYP2D6 polymorphisms), drug–drug interactions (e.g., concomitant use of CYP2D6 inhibitors), other factors (e.g., food, lifestyle, gender, age), tamoxifen dose, treatment adherence, and additional unknown factors.